Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
316
NCT04688671
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 9, 2020
Completion: Feb 18, 2022
NCT04778592
Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
Start: Jan 19, 2021
Completion: May 25, 2022